Tafamidis Form-1
Systematic Name
2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid
Therapeutic Category
Transthyretin amyloidosis
CAS No
594839-88-0
Suitable Formulations
Solid
Approvals
US DMF
- Business Enquiry - enquiry@sthreechemicals.com
2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid
Transthyretin amyloidosis
594839-88-0
Solid
US DMF
Sthree Chemicals excels in pharmaceutical chemistry, offering quality, reliability, transparency, and trusted partnership for global pharmaceutical success.
Sthree chemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.